Return to Article Details THE USE OF ANTITUBERCULOSIS THERAPY CAUSES AN INCREASE OF URIC ACID LEVELS IN PATIENTS WITH TB-MDR (TUBERCULOSIS MULTI DRUG RESISTANT) Download Download PDF